X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA UNICHEM LAB NATCO PHARMA/
UNICHEM LAB
 
P/E (TTM) x 30.7 32.8 93.5% View Chart
P/BV x 23.2 3.5 672.3% View Chart
Dividend Yield % 0.5 0.5 89.6%  

Financials

 NATCO PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
UNICHEM LAB
Mar-16
NATCO PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs877334 262.6%   
Low Rs424174 243.4%   
Sales per share (Unadj.) Rs223.4146.9 152.1%  
Earnings per share (Unadj.) Rs31.111.9 261.2%  
Cash flow per share (Unadj.) Rs40.316.2 248.8%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.80.8 97.7%  
Book value per share (Unadj.) Rs219.5105.1 208.8%  
Shares outstanding (eoy) m33.0790.84 36.4%   
Bonus/Rights/Conversions PAESOP-  
Price / Sales ratio x2.91.7 168.3%   
Avg P/E ratio x20.921.4 98.0%  
P/CF ratio (eoy) x16.115.7 102.9%  
Price / Book Value ratio x3.02.4 122.6%  
Dividend payout %16.116.8 95.7%   
Avg Mkt Cap Rs m21,50423,073 93.2%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1,1282,558 44.1%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m7,38913,346 55.4%  
Other income Rs m167192 87.1%   
Total revenues Rs m7,55613,538 55.8%   
Gross profit Rs m1,7931,639 109.4%  
Depreciation Rs m304390 78.1%   
Interest Rs m36629 1,271.5%   
Profit before tax Rs m1,2901,412 91.3%   
Minority Interest Rs m460-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m309293 105.5%   
Profit after tax Rs m1,0271,080 95.1%  
Gross profit margin %24.312.3 197.6%  
Effective tax rate %23.920.7 115.5%   
Net profit margin %13.98.1 171.8%  
BALANCE SHEET DATA
Current assets Rs m3,6815,979 61.6%   
Current liabilities Rs m3,1232,432 128.4%   
Net working cap to sales %7.626.6 28.4%  
Current ratio x1.22.5 47.9%  
Inventory Days Days8963 141.9%  
Debtors Days Days5960 97.2%  
Net fixed assets Rs m7,6856,403 120.0%   
Share capital Rs m331182 182.0%   
"Free" reserves Rs m6,6709,293 71.8%   
Net worth Rs m7,2599,548 76.0%   
Long term debt Rs m955230 414.5%   
Total assets Rs m11,95712,843 93.1%  
Interest coverage x4.550.0 9.0%   
Debt to equity ratio x0.10 545.2%  
Sales to assets ratio x0.61.0 59.5%   
Return on assets %11.78.6 134.9%  
Return on equity %14.211.3 125.1%  
Return on capital %20.714.3 144.6%  
Exports to sales %39.429.2 134.7%   
Imports to sales %5.76.3 89.8%   
Exports (fob) Rs m2,9083,900 74.6%   
Imports (cif) Rs m421847 49.7%   
Fx inflow Rs m3,4454,356 79.1%   
Fx outflow Rs m7031,162 60.5%   
Net fx Rs m2,7433,194 85.9%   
CASH FLOW
From Operations Rs m1,4401,119 128.7%  
From Investments Rs m-1,089-853 127.6%  
From Financial Activity Rs m-353-334 105.5%  
Net Cashflow Rs m-1-68 2.2%  

Share Holding

Indian Promoters % 52.0 50.1 103.9%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 15.1 51.9%  
FIIs % 16.6 3.0 554.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 31.7 82.0%  
Shareholders   25,395 20,176 125.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 19, 2018 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ALEMBIC PHARMA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS